Cardiac fat accumulation emerges as a critical but overlooked predictor of heart complications, potentially reshaping how physicians assess risk in patients with thickened heart muscle. This finding challenges the traditional focus on structural abnormalities alone when evaluating cardiovascular prognosis.
Analysis of 457 hypertrophic cardiomyopathy patients revealed that those experiencing major cardiovascular events carried significantly more epicardial adipose tissue—fat surrounding the heart—with volumes averaging 72.21 mL/m² compared to 56.71 mL/m² in event-free patients. Each unit increase in fat volume index corresponded to a 3% higher risk of adverse outcomes over nearly three years of follow-up. The tissue measurements, obtained through cardiac MRI scanning, demonstrated independent predictive value even after accounting for established clinical risk factors.
This represents a meaningful advance in cardiovascular risk stratification, where current European guidelines rely primarily on structural heart measurements and family history. Adding epicardial fat volume to existing risk models improved predictive accuracy from 71% to 80%—a clinically significant enhancement that could influence treatment decisions for thousands of patients. The research builds on emerging understanding of adipose tissue as an active endocrine organ rather than passive storage, particularly around the heart where inflammatory signals directly affect cardiac function. However, the retrospective design and single-center approach limit broader generalizability. The 62.5 mL/m² threshold identified here requires validation across diverse populations before clinical implementation. Still, this work positions cardiac fat assessment as a potentially routine component of cardiomyopathy evaluation, offering physicians a more nuanced tool for identifying high-risk patients who might benefit from aggressive preventive interventions.